EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An in vitro larval motility assay characterizes anthelmintic efficacy against Crenosoma vulpis, Angiostrongylus vasorum, and Aelurostrongylus abstrusus

Haifaa A Mahjoub, Daniela Bedenice, Henrik Stryhn, Jenny Yu, Spencer J Greenwood, Gary A Conboy

American Journal of Veterinary Research · 2024

DOI: 10.2460/ajvr.23.06.0123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Haifaa A Mahjoub und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Department, College of Sciences & Arts, King Abdulaziz University, Rabigh 21911, Saudi Arabia. Hauptthemen laut MEDLINE: Angiostrongylus, Cat Diseases, Dog Diseases, Metastrongyloidea. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE This study determined the in vitro efficacy of 6 common anthelmintics (eprinomectin, ivermectin, milbemycin oxime, moxidectin, selamectin, and fenbendazole) on motility (viability) of infectious third-stage larvae (L 3 ) of Crenosoma vulpis, Angiostrongylus vasorum , and Aelurostrongylus abstrusus , which are important causes of canine and feline cardiopulmonary disease. SAMPLES First-stage larvae (L 1 ) from C vulpis, An vasorum , and Ae abstrusus. PROCEDURES Naïve Limax maximus slugs were fed 1,000 to 2,000 L 1 and held at 16 °C for at least 4 weeks to produce live L 3 . Approximately 50 to 100 L 3 /well were subsequently incubated in culture media alone or media containing 6 separate test anthelmintics at 4 concentrations, to bracket expected in vivo drug plasma levels in anthelmintic-treated dogs and cats. Drug effects on L 3 motility (viability) were analyzed by multilevel logistic models, generating dose-response relationships. Experiments were completed 1-9/2019. RESULTS Drug concentration estimates corresponding to a 50% larval mortality rate identified that C vulpis was the most sensitive species to the anthelmintics tested. Ae abstrusus was most susceptible to moxidectin and selamectin, while An vasorum was insusceptible to all anthelmintics tested, except for selamectin at high drug concentrations. CLINICAL RELEVANCE The in vitro anthelmintic response to antiparasitic agents may guide and improve disease therapy and prevention. Considering the observed lack of efficacy against L 3 , monthly anthelmintic treatment for protection against An vasorum infection in dogs would primarily rely on the anthelmintic’s adulticidal activity. Maximal preventive control for An vasorum would, therefore, require at least 1 treatment administered a minimum of 1 week after the end of the transmission season.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngiostrongylusCat DiseasesDog DiseasesMetastrongyloideaAnthelminticsMacrolidesAnimalsCatsDogsLarvaIvermectin

Stichwörter der Autor:innen

Aelurostrongylus abstrususAngiostrongylus vasorumCrenosoma vulpisantilarvalantiparasitic

Substanzen

moxidectinselamectinAnthelminticsIvermectinMacrolides

Autor:innen und Institutionen

  • Biological Sciences Department, College of Sciences & Arts, King Abdulaziz University, Rabigh 21911, Saudi Arabia.
  • Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA.
  • Department of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada.
  • Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada.
  • Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada.

Zitieren

APA

Mahjoub, H. A., Bedenice, D., Stryhn, H., Yu, J., Greenwood, S. J., & Conboy, G. A. (2024). An in vitro larval motility assay characterizes anthelmintic efficacy against Crenosoma vulpis, Angiostrongylus vasorum, and Aelurostrongylus abstrusus. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.23.06.0123

Vancouver

Mahjoub HA, Bedenice D, Stryhn H, Yu J, Greenwood SJ, Conboy GA. An in vitro larval motility assay characterizes anthelmintic efficacy against Crenosoma vulpis, Angiostrongylus vasorum, and Aelurostrongylus abstrusus. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.23.06.0123

BibTeX
@article{Mahjoub2024,
  author = {Mahjoub, Haifaa A and Bedenice, Daniela and Stryhn, Henrik and Yu, Jenny and Greenwood, Spencer J and Conboy, Gary A},
  title = {An in vitro larval motility assay characterizes anthelmintic efficacy against Crenosoma vulpis, Angiostrongylus vasorum, and Aelurostrongylus abstrusus},
  journal = {American Journal of Veterinary Research},
  year = {2024},
  doi = {10.2460/ajvr.23.06.0123}
}
Kostenlos starten →